Melpomeni Fani

9PUBLICATIONS
14CO-AUTHORS
Predictive and prognostic markersCharacterisation of biological macromoleculesCancer therapy (excl. chemotherapy and radiation therapy)Gene and molecular therapyCheminformatics and quantitative structure-activity relationships
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Aug 21, 2025
Enhanced contrast in FAP-targeting PET imaging with <sup>61</sup>Cu-labeled FAP inhibitors: development and preclinical evaluation of novel [<sup>61</sup>Cu]Cu-Kalios PET radioligands.

Jacopo Millul, Tais Basaco Bernabeu, Raghuvir H Gaonkar

|Jul 01, 2025
Pyridyl-Ala in the third position of radiolabeled somatostatin antagonists: the effect of regioisomeric substitution.

Rosalba Mansi, Natalie Bertarelli, Luigi Del Pozzo

|Jan 09, 2025
Improving Affinity while Reducing Kidney Uptake of CXCR4-Targeting Radioligands Derived from the Endogenous Antagonist EPI-X4.

Raghuvir H Gaonkar, Thibaud Bailly, Jacopo Millul

|Jun 01, 2023
Head-to-head comparison of different classes of FAP radioligands designed to increase tumor residence time: monomer, dimer, albumin binders, and small molecules vs peptides.

Jacopo Millul, Lennart Koepke, Gaonkar Raghuvir Haridas

|Mar 29, 2023
Development of the <sup>99m</sup>Tc-Labelled SST<sub>2</sub> Antagonist TECANT-1 for a First-in-Man Multicentre Clinical Study.

Doroteja Novak, Barbara Janota, Anton Amadeus Hörmann

|Mar 10, 2022
Radiolabeled Somatostatin Analogs-A Continuously Evolving Class of Radiopharmaceuticals.

Melpomeni Fani, Rosalba Mansi, Guillaume P Nicolas

Pageof 2

Frequent Collaborators

5 joint publications

Rosalba Mansi

1 joint publications

Guillaume P Nicolas

1 joint publications

Barbara Janota

1 joint publications

Agnieszka Sawicka